Marco Fischer

MD PhD | Pediatrician | Clinican-scientist in immunology @Unispital_USZ l Research on T cell metabolism and autoimmunity in IEI. Views are my own

[Marco Fischer @marcofischerMD]

https://t.co/TVTPem3AID

[Marco Fischer @marcofischerMD]

@PDehio @snsf_ch @ISTAustria @Sixt_Lab Congratulations, well deserved

[Marco Fischer @marcofischerMD]

@jacionline Excited to see the result of our retrospectiv study. Thanks to @petolb_huvr @HadjadjJerome @Siobhan13592648 @BenedicteNeven and to Stephan Ehl and Carsten Speckmann @Uniklinik_Fr, all contributing colleagues and patients

[Journal of Allergy and Clinical Immunology @jacionline]

Janus kinase inhibitors offer targeted treatment for patients with inborn errors of JAK/signal transducer and activator of transcription (STAT) signaling, but data on efficacy and risk for adverse events are limited. New results show promise. https://t.co/Yt4RVE4hzY

[Marketa Bloomfield @BloomfieldM_1]

To all of us managing #IEI patients with JAK/STAT dysregulation

👉Don ´t miss this latest multinational report of our collective experience with JAKinib treatments

Thank you Marco Fisher, @CS_Freiburg and all co-authors. This is pivotal work👍

https://t.co/S39iR4fDR7

[ESID @ESIDsociety]

Coming Soon! The New ESID Grand Rounds Webinar on January 24, 2023, at 17:00 (CET), will focus on JAKinh in IEIs of the JAK/STAT pathway. Find out more and register here: https://t.co/bj1xjUFp51
#esid #primaryimmunodeficiency #iei #Immunology